Gene Silencing/Gene Editing
News on CRISPR, gene editing, RNAi in genetics, genomics, and molecular diagnostics.
Jumpcode Genomics, TGen Partner to Test Metagenomic Approaches for COVID Detection
The company and institute are collaborating on the development of a diagnostic assay that uses Jumpcode's CRISPR-based reagents and TGen's NGS technology.
The point-of-care system can detect SARS-CoV-2 in unprocessed patient saliva in about an hour, according to the researchers.
Synthetic biology and CRISPR have enabled researchers to develop wearable sensors that can detect a variety of viruses and bacteria, including SARS-CoV-2.
Sherlock Biosciences Foundation Grants License to Rokline Health for COVID-19 CRISPR Tests
Sherlock Biosciences said that under the agreement, Rokline Health will develop and manufacture high-throughput CRISPR kits in the US.
Sherlock Bio Foundation Licenses CRISPR Tech to LogicInk
LogicInk said it will use the CRISPR technology to develop an instrument-free diagnostic biosensor for the detection of SARS-CoV-2.